Adenovirus-mediated expression of tissue plasminogen activator does not alter endothelial cell proliferation and invasion [3]

In Vitro Cellular and Developmental Biology - Animal

Volumn 36, Issue 10, 2000, Pages 625-628

  Zablocki, Daniela K ^b   Rade, Jeffrey J ^a   Alevriadou, B Rita ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CATHEPSIN G; PLASMIN; PLASMINOGEN; TISSUE KALLIKREIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADENOVIRUS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TRANSFER; HUMAN; HUMAN CELL; LETTER; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

ADENOVIRIDAE; ANIMALS; CATTLE; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE PLASMINOGEN ACTIVATOR;

ADENOVIRIDAE;

EID: 0034468352     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1290/1071-2690(2000)036<0625:AMEOTP>2.0.CO;2     Document Type: Letter

References (18)

1. Use of recombinant adenovirus for metabolic engineering of mammalian cells
2. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice
3. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice
4. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
5. Enhanced in vive antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors
6. Matrix metalloproteinases and cardiovascular disease
7. Ex vivo cultured megakaryocytes express functional glycoprotein IIb-IIIa receptors and are capable of adenovirus-mediated transgene expression
8. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
9. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor
10. Plasminogen activators and matrix metalloproteinases in angiogenesis
11. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases
12. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity
13. Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries
14. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways
15. Endothelium-specific in vivo gene transfer
16. Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells
17. Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism
18. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha-macroglobulin receptor associated protein